RxSight Inc. (RXST)
Company Description
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally.
It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery.
The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery.
It primarily serves cataract doctors.
The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017.
RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Country | United States |
IPO Date | Jul 30, 2021 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 498 |
CEO | Dr. Ronald M. Kurtz M.D. |
Contact Details
Address: 100 Columbia Aliso Viejo, California United States | |
Website | https://www.rxsight.com |
Stock Details
Ticker Symbol | RXST |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001111485 |
CUSIP Number | 78349D107 |
ISIN Number | US78349D1072 |
Employer ID | 94-3268801 |
SIC Code | 3851 |
Key Executives
Name | Position |
---|---|
Dr. Ronald M. Kurtz M.D. | Co-President, Chief Executive Officer & Director |
Eric J. Weinberg | Co-President & Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 21, 2025 | DEF 14A | Filing |
Apr 21, 2025 | ARS/A | [Amend] Filing |
Apr 21, 2025 | DEFA14A | Filing |
Apr 15, 2025 | 4 | Filing |
Apr 08, 2025 | SCHEDULE 13G | Filing |
Apr 03, 2025 | 8-K | Current Report |
Mar 13, 2025 | 4 | Filing |
Feb 27, 2025 | 4 | Filing |
Feb 27, 2025 | 4 | Filing |
Feb 27, 2025 | 4 | Filing |